Effect of angiotensin II on passive avoidance performance after bilateral lesion of the nucleus accumbens septi. 1985

M M Winnicka, and J Braszko, and J Boguszewicz, and K Wiśniewski

The experiments performed earlier in this Department indicated that facilitatory effect of angiotensin II (AII) on recall is connected with its influence on dopaminergic systems. In an attempt to evaluate the possible site of action of AII on the memory processes, bilateral lesion of the nucleus accumbens septi (NAS, a limbic structure which receives projection from A 10 dopaminergic neurons) was made before behavioral testing of the influence of icv injection of AII on recall in passive avoidance situation. Unexpectedly, bilateral lesion of the NAS improved the recall itself. In such a situation any facilitatory action of AII on recall in this test could not be shown.

UI MeSH Term Description Entries
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D008032 Limbic System A set of forebrain structures common to all mammals that is defined functionally and anatomically. It is implicated in the higher integration of visceral, olfactory, and somatic information as well as homeostatic responses including fundamental survival behaviors (feeding, mating, emotion). For most authors, it includes the AMYGDALA; EPITHALAMUS; GYRUS CINGULI; hippocampal formation (see HIPPOCAMPUS); HYPOTHALAMUS; PARAHIPPOCAMPAL GYRUS; SEPTAL NUCLEI; anterior nuclear group of thalamus, and portions of the basal ganglia. (Parent, Carpenter's Human Neuroanatomy, 9th ed, p744; NeuroNames, http://rprcsgi.rprc.washington.edu/neuronames/index.html (September 2, 1998)). Limbic Systems,System, Limbic,Systems, Limbic
D008297 Male Males
D008845 Microinjections The injection of very small amounts of fluid, often with the aid of a microscope and microsyringes. Microinjection
D009714 Nucleus Accumbens Collection of pleomorphic cells in the caudal part of the anterior horn of the LATERAL VENTRICLE, in the region of the OLFACTORY TUBERCLE, lying between the head of the CAUDATE NUCLEUS and the ANTERIOR PERFORATED SUBSTANCE. It is part of the so-called VENTRAL STRIATUM, a composite structure considered part of the BASAL GANGLIA. Accumbens Nucleus,Nucleus Accumbens Septi,Accumbens Septi, Nucleus,Accumbens Septus, Nucleus,Accumbens, Nucleus,Nucleus Accumbens Septus,Nucleus, Accumbens,Septi, Nucleus Accumbens,Septus, Nucleus Accumbens
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D006892 Hydroxydopamines Dopamines with a hydroxy group substituted in one or more positions. Hydroxydopamine
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001362 Avoidance Learning A response to a cue that is instrumental in avoiding a noxious experience. Aversion Behavior,Aversion Learning,Aversive Behavior,Aversive Learning,Avoidance Behavior,Aversion Behaviors,Aversive Behaviors,Avoidance Behaviors,Behavior, Aversion,Behavior, Aversive,Behavior, Avoidance,Behaviors, Aversion,Behaviors, Aversive,Behaviors, Avoidance,Learning, Aversion,Learning, Aversive,Learning, Avoidance

Related Publications

M M Winnicka, and J Braszko, and J Boguszewicz, and K Wiśniewski
September 1976, Cell and tissue research,
M M Winnicka, and J Braszko, and J Boguszewicz, and K Wiśniewski
January 1990, Journal of neural transmission. Parkinson's disease and dementia section,
M M Winnicka, and J Braszko, and J Boguszewicz, and K Wiśniewski
June 1975, Brain research,
M M Winnicka, and J Braszko, and J Boguszewicz, and K Wiśniewski
January 1986, Psychopharmacology,
M M Winnicka, and J Braszko, and J Boguszewicz, and K Wiśniewski
September 2001, Brain research. Developmental brain research,
M M Winnicka, and J Braszko, and J Boguszewicz, and K Wiśniewski
January 1986, Journal fur Hirnforschung,
M M Winnicka, and J Braszko, and J Boguszewicz, and K Wiśniewski
January 1995, Alcohol (Fayetteville, N.Y.),
M M Winnicka, and J Braszko, and J Boguszewicz, and K Wiśniewski
January 1984, Psychopharmacology,
M M Winnicka, and J Braszko, and J Boguszewicz, and K Wiśniewski
January 1979, Applied neurophysiology,
M M Winnicka, and J Braszko, and J Boguszewicz, and K Wiśniewski
January 1978, Polish journal of pharmacology and pharmacy,
Copied contents to your clipboard!